Sold out of itself: management is turning demand away today because the company cannot supply it, and the fix is already
The model's full reasoning — Q2 2021 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management describe that the company is CURRENTLY FAILING TO SERVE DEMAND IT ALREADY HAS — real, identified buyers being turned away, etc. And does management describe the company already spending or committing to remove that limit? We need all three conditions: (1) demand already there and going unserved due to company's own ability to produce/deliver/serve, (2) management treats it as material, (3) company already acting to close the gap. In the transcript, management discusses COVID-19 impacts on physicians' practices, patients not visiting, new patients not being seen, etc. They talk about new patient enrollments increasing, but also mention that they are impacted by COVID. They say "market dynamics remain a challenge" and "physicians' practices that are not yet fully functional or not open to new patients or unwilling to prescribe new medications for patients without several in-person visits." They mention "undiagnosed patients or newly diagnosed patients trying to get treatment." They also say "we have a robust pipeline of patient leads that are already diagnosed with LEMS, but not yet on therapy. Many of these patients are waiting to visit with their physician." That suggests there is demand but it's not being served because patients can't get in to see physicians. However, that's not because the company's own supply capacity is limited; it's because of external factors (COVID, physician practices). The company can supply the drug if prescriptions are written. The limitation is not the company's ability to produce or deliver. The limitation is the market/physician access. So condition (1) fails because the shortfall is not the company's own ability to produce, deliver, staff, install, or serve. It's a lack of buyers visiting physicians, not a lack of supply. They are not turning away orders; they are unable to get new patients because physicians aren't seeing patients. So they are not failing to serve demand due to company capacity constraints. They are serving all demand that comes in. They have high persistency, low discontinuations. They are not rationing or waiting lists. They mention "pipeline of patient leads" that are waiting to visit with physician - that's not the company's capacity, that's patient/physician behavior.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| ZBH | Zimmer Biomet Holdings, Inc. | Q2 2017 | 2017-07-30 | F |
OGI · Q3 2022 → YESThe question is: Does management describe that the company is CURRENTLY FAILING TO SERVE DEMAND IT ALREADY HAS — real buyers being turned away, etc., because they can't supply, AND already spending or...YES The transcript shows management describing a current situation where demand is outstripping supply ("we have been really tight on our supply. Our demand was outstripping our supply"), leading to turning away or limiting sales to certain provinces ("we were really stealing from 1 pocket to the other as we're trying to balance the demand to what available capacity we had" and limiting SHRED distribution). This is material, as it affects their ability to serve existing customers fully.
CRL · Q2 2022 → YESThe question is whether management describes the company currently failing to serve demand it already has, and already spending or committing to remove that limit. YES The transcript shows clients securing space in take-or-pay arrangements because of tight capacity, indicating unserved demand from existing buyers. Management notes capacity is well utilized and they are hiring staff to accommodate higher forecasted demand, confirming they are already acting to close the gap. This situation is material given the backlog growth and emphasis on availability over price.
BRBR · Q4 2023 → YESThe question is whether management describes the company currently failing to serve demand it already has, and already spending or committing to remove that limit. NO The transcript shows ongoing capacity constraints and tight supply dynamics, with management noting they are holding back on marketing/promotions due to limited supply and that they lost customers in prior years due to capacity.